David Warburton

David Warburton, MD is a Professor of Pediatrics at the University of Southern California (USC), affiliated with the Saban Research Institute at Children's Hospital Los Angeles (CHLA). His work bridges neonatal-perinatal medicine, developmental biology, and regenerative medicine, with a focus on lung morphogenesis, repair, and fibrosis. He has pioneered studies on molecular embryology of the lung, including growth factor and extracellular matrix roles in lung development and disease.

Warburton's research spans clinical and basic science, including management practices for extreme prematurity, fetal lung maturation, and pediatric interstitial lung diseases. He collaborates internationally, particularly in the UK, and mentors doctoral and postdoctoral fellows. His awards include the Order of the British Empire (2009) for UK/US scientific collaboration and fellowships from Royal Colleges of Surgeons, Physicians, and Paediatrics.

Key research areas include environmental health impacts (e.g., air pollution in Mongolia), post-COVID-19 pediatric sequelae, and clinical trials for nintedanib in fibrosing interstitial lung diseases. His studies leverage stem cells, extracellular vesicles, and molecular signaling pathways to advance regenerative therapies.

• Awards: OBE (2009), Royal College Fellowships
• Grants: NIH, CIRM, UK MRC/BBSRC
• Key Projects: LungMAP molecular atlas, Mongolian air pollution cohort studies